Home › Breast Cancer › NCT03408353

Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

MERIT (Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies) Cohort

Who can join

Ages 25 to 80 · Women · Healthy volunteers welcome

Inclusion Criteria:

* Willingness to participate in the study and ability to provide informed consent
* Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits
* Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible.

Exclusion Criteria:

* Current or recent (within the prior 6 months) history of breast feeding
* Personal history of breast cancer (ductal breast carcinoma in situ \[DCIS\] or invasive breast cancer)
* Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.

About the study

This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.

What is being tested

• Biospecimen Collection (procedure)
• Mammography (procedure)
• Questionnaire Administration (other)

Sponsor: M.D. Anderson Cancer Center · Participants: 10,000 · Started: Sep 15, 2017

Contact the study team

• Jessica Leung · Phone: 713-745-4555

Official record on ClinicalTrials.gov — NCT03408353

Locations in the U.S.

Conditions

• Breast Cancer

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.